Most NCCN cancer centers have been affected by shortages of the chemotherapy drugs carboplatin and cisplatin, a survey suggests.
Jen Smith
Jen Smith is the medical editor of Cancer Therapy Advisor. She was previously the editor of Hematology Times and the oncology editor for MDedge Hematology/Oncology. She has a BS in journalism.
